tradingkey.logo

aTyr Pharma Inc <ATYR.OQ> expected to post a loss of 19 cents a share - Earnings Preview

ReutersApr 28, 2025 11:35 AM
  • aTyr Pharma Inc ATYR.OQ ATYR.O is expected to show a fall in quarterly revenue when it reports results on April 30 (estimated) for the period ending March 31 2025

  • ​LSEG's mean analyst estimate for aTyr Pharma Inc is for a loss of 19 cents per share.

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 11 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."

  • The mean earnings estimate of analysts had risen by about 0.8% in the last three months. ​

  • Wall Street's median 12-month price target for aTyr Pharma Inc is $16.50​, above​ its last closing price of $3.35. ​​​

Previous quarterly performance (using preferred earnings measure in US dollars). ​

QUARTER ENDING

STARMINESMARTESTIMATE®

LSEG IBES ESTIMATE

ACTUAL

BEAT, MET, MISSED

SURPRISE %

Dec. 31 2024

-0.21

-0.23

-0.18

Beat

20.4

Sep. 30 2024

-0.22

-0.22

-0.23

Missed

-4.5

Jun. 30 2024

-0.24

-0.24

-0.23

Beat

3.4​

Mar. 31 2024

-0.25

-0.24

-0.23

Beat

2.5

​​Dec. 31 2023

-0.24

-0.25

Missed

-5

Sep. 30 2023

-0.22

-0.23

-0.20

Beat

11.5​

Jun. 30 2023

-0.28

-0.28

-0.22

Beat

21

Mar. 31 2023

-0.40

-0.40

-0.29

Beat

27.2

This summary was machine generated April 28 at 11:35 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI